Equities

Nutex Befektetesi Nyrt

NUTEX:BUD

Nutex Befektetesi Nyrt

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HUF)14.25
  • Today's Change-0.05 / -0.35%
  • Shares traded227.44k
  • 1 Year change-12.58%
  • Beta1.0975
Data delayed at least 15 minutes, as of May 23 2024 15:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.

  • Revenue in HUF (TTM)450.00k
  • Net income in HUF73.09m
  • Incorporated1996
  • Employees1.00
  • Location
    Nutex Befektetesi NyrtTelepes u. 53.BUDAPEST 1147HungaryHUN
  • Phone+36 18017081
  • Fax+36 18017082
  • Websitehttp://www.nutex.hu/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Spexis AG0.00-4.88bn1.85bn----0.2124-----0.2547-0.25470.000.32960.00-------35.86-50.41-44.63-62.27-------892.14----0.3098-------56.41---62.03--
ValiRx Plc4.35m-923.87m1.86bn8.00--0.9855--427.38-0.0201-0.02010.000090.03150.0027--0.0682---59.88-50.57-58.27-54.7785.00---22,164.48-103,908.502.32-520.030.0075------13.89---1.13--
Orphazyme A/S0.00-1.35bn1.86bn1.00--2.53-----737.75-737.750.00403.340.00----0.00-68.42-76.08-94.18-105.34------------0.00------32.00------
PCI Biotech Holding ASA99.99m-679.39m1.87bn7.00--1.43--18.73-0.5443-0.54430.08011.050.0556--0.6848427,142.80-37.78-36.44-41.97-40.14-----679.43-1,055.43----0.0081---37.05-20.7863.13------
Immunovia AB (publ)40.29m-8.67bn1.92bn11.00--1.32--47.75-6.06-6.060.02760.96480.007558.2314.96110,181.80-160.93-41.33-194.89-44.24-5,523.76-7,553.76-21,512.13-20,879.292.03--0.1675--37.5536.48-84.09---50.93--
Prolight Diagnostics AB (publ)0.00-4.55bn1.99bn16.00--0.4824-----0.3953-0.39530.000.24880.00----0.00-64.42---84.94--------------0.00-----------13.84--
Klaria Pharma Holding AB (publ)0.00-611.17m2.03bn5.00--1.22-----0.1824-0.3550.000.38620.00----0.00-19.03-37.28-31.28-51.56-------2,077.34---3.880.00---100.00--71.17------
Combigene AB184.30m-1.19bn2.09bn8.00--0.5407--11.36-1.80-1.800.285.880.0398--2.63693,015.00-25.58-13.00-26.56-14.58-----643.32-58.77----0.00---79.23268.58-479.27---24.02--
NUTEX Befektetesi Nyrt450.00k73.09m2.12bn1.0028.860.401528.914,706.630.49550.49550.00335.620.00009--0.0148--1.39-1.401.40-1.4150.00--16,242.67-3,393.18702.09--0.00--0.00-44.77952.46------
Pila Pharma AB48.63m-330.10m2.14bn1.00--9.64--43.91-0.5304-0.53040.07670.280.1513--6.111,463,020.00-102.68-108.88-122.66-121.45-127.88-42.67-678.73-1,577.64---159.470.104---22.21--62.92------
ExpreS2ion Biotech Holding AB258.20m-2.59bn2.19bn18.00--1.26--8.50-1.56-1.560.15091.020.0821--4.87298,730.80-82.36-63.54-113.92-75.88-132.91-1.94-1,003.55-524.31----0.0055--43.07-0.156122.94--19.90--
Pure Biologics SA-9.06tn-9.06tn2.21bn29.00---------------0.9246-----------48.68---83.38--38.81---195.73----1.30--160.63-7.58-117.62------
BSF Enterprise PLC5.87m-680.56m2.23bn4.00--1.01--379.33-0.0159-0.01590.00010.0470.00282.110.08373,235.00-32.30---34.46---451.16---11,600.08--8.16-154.860.0313-------61.40------
Double Bond Phrmcutcl Intrntnl AB (publ)49.56m-534.23m2.23bn10.00--10.41--45.00-0.1635-0.16350.01450.06380.1306--26.83149,078.00-140.73-80.90-200.07-106.45-389.14-1,073.66-1,078.00-1,360.03---2.710.00--10.25135.07-14.36------
ViroGates A/S296.67m-659.78m2.34bn10.00--3.36--7.87-6.00-6.001.442.080.33440.3163.64573,300.00-74.36-46.58-80.05-52.0977.2077.91-222.40-238.0110.45-19.080.2833---45.0110.98-25.40------
Data as of May 23 2024. Currency figures normalised to Nutex Befektetesi Nyrt's reporting currency: Hungarian Forint HUF
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.